Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 68

1.

Aggressiveness in depression: a neglected symptom possibly associated with bipolarity and mixed features.

Verdolini N, Perugi G, Samalin L, Murru A, Angst J, Azorin JM, Bowden CL, Mosolov S, Young AH, Barbuti M, Guiso G, Popovic D, Vieta E, Pacchiarotti I; BRIDGE-II-Mix Study Group.

Acta Psychiatr Scand. 2017 Oct;136(4):362-372. doi: 10.1111/acps.12777. Epub 2017 Jul 25.

PMID:
28741646
2.

Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review.

Solmi M, Murru A, Pacchiarotti I, Undurraga J, Veronese N, Fornaro M, Stubbs B, Monaco F, Vieta E, Seeman MV, Correll CU, Carvalho AF.

Ther Clin Risk Manag. 2017 Jun 29;13:757-777. doi: 10.2147/TCRM.S117321. eCollection 2017. Review.

3.

Obesity in patients with major depression is related to bipolarity and mixed features: evidence from the BRIDGE-II-Mix study.

Petri E, Bacci O, Barbuti M, Pacchiarotti I, Azorin JM, Angst J, Bowden CL, Mosolov S, Vieta E, Young AH, Perugi G; BRIDGE-II-Mix Study Group.

Bipolar Disord. 2017 Jul 10. doi: 10.1111/bdi.12519. [Epub ahead of print]

PMID:
28691250
4.

A study on the bioequivalence of lithium and valproate salivary and blood levels in the treatment of bipolar disorder.

Murru A, Torra M, Callari A, Pacchiarotti I, Romero S, Gonzalez de la Presa B, Varo C, Goikolea JM, Pérez-Sola V, Vieta E, Colom F.

Eur Neuropsychopharmacol. 2017 Aug;27(8):744-750. doi: 10.1016/j.euroneuro.2017.06.003. Epub 2017 Jun 28.

PMID:
28666638
5.

The aggressor at the mirror: Psychiatric correlates of deliberate self-harm in male prison inmates.

Verdolini N, Murru A, Attademo L, Garinella R, Pacchiarotti I, Bonnin CDM, Samalin L, Pauselli L, Piselli M, Tamantini A, Quartesan R, Carvalho AF, Vieta E, Tortorella A.

Eur Psychiatry. 2017 Jul;44:153-160. doi: 10.1016/j.eurpsy.2017.04.002. Epub 2017 Apr 14.

PMID:
28641217
6.

Thyroid autoimmunity in bipolar disorder: A systematic review.

Barbuti M, Carvalho AF, Köhler CA, Murru A, Verdolini N, Guiso G, Samalin L, Maes M, Stubbs B, Perugi G, Vieta E, Pacchiarotti I.

J Affect Disord. 2017 Oct 15;221:97-106. doi: 10.1016/j.jad.2017.06.019. Epub 2017 Jun 13. Review.

PMID:
28641149
7.

Antidepressant-induced hypomania/mania in patients with major depression: Evidence from the BRIDGE-II-MIX study.

Barbuti M, Pacchiarotti I, Vieta E, Azorin JM, Angst J, Bowden CL, Mosolov S, Young AH, Perugi G; BRIDGE-II-Mix Study Group.

J Affect Disord. 2017 Sep;219:187-192. doi: 10.1016/j.jad.2017.05.035. Epub 2017 May 24.

PMID:
28558366
8.

Modifiable and non-modifiable factors associated with functional impairment during the inter-episodic periods of bipolar disorder.

Murru A, Pacchiarotti I, Verdolini N, Reinares M, Torrent C, Geoffroy PA, Bellivier F, Llorca PM, Vieta E, Samalin L.

Eur Arch Psychiatry Clin Neurosci. 2017 May 22. doi: 10.1007/s00406-017-0811-0. [Epub ahead of print]

PMID:
28534186
9.

Systematic assessment of environmental risk factors for bipolar disorder: an umbrella review of systematic reviews and meta-analyses.

Bortolato B, Köhler CA, Evangelou E, León-Caballero J, Solmi M, Stubbs B, Belbasis L, Pacchiarotti I, Kessing LV, Berk M, Vieta E, Carvalho AF.

Bipolar Disord. 2017 Mar;19(2):84-96. doi: 10.1111/bdi.12490. Epub 2017 May 3. Review.

PMID:
28470927
10.

Residual depressive symptoms, sleep disturbance and perceived cognitive impairment as determinants of functioning in patients with bipolar disorder.

Samalin L, Boyer L, Murru A, Pacchiarotti I, Reinares M, Bonnin CM, Torrent C, Verdolini N, Pancheri C, de Chazeron I, Boucekine M, Geoffroy PA, Bellivier F, Llorca PM, Vieta E.

J Affect Disord. 2017 Mar 1;210:280-286. doi: 10.1016/j.jad.2016.12.054. Epub 2017 Jan 3.

PMID:
28068616
11.

Mood stabilizers and antipsychotics during breastfeeding: Focus on bipolar disorder.

Pacchiarotti I, León-Caballero J, Murru A, Verdolini N, Furio MA, Pancheri C, Valentí M, Samalin L, Roigé ES, González-Pinto A, Montes JM, Benabarre A, Crespo JM, de Dios Perrino C, Goikolea JM, Gutiérrez-Rojas L, Carvalho AF, Vieta E.

Eur Neuropsychopharmacol. 2016 Oct;26(10):1562-78. doi: 10.1016/j.euroneuro.2016.08.008. Epub 2016 Aug 24. Review.

PMID:
27568278
12.

Course of residual symptoms according to the duration of euthymia in remitted bipolar patients.

Samalin L, Reinares M, de Chazeron I, Torrent C, Bonnin CM, Hidalgo-Mazzei D, Murru A, Pacchiarotti I, Geoffroy PA, Bellivier F, Llorca PM, Vieta E.

Acta Psychiatr Scand. 2016 Jul;134(1):57-64. doi: 10.1111/acps.12568. Epub 2016 Mar 30.

PMID:
27028581
13.

Assessment and management of agitation in psychiatry: Expert consensus.

Garriga M, Pacchiarotti I, Kasper S, Zeller SL, Allen MH, Vázquez G, Baldaçara L, San L, McAllister-Williams RH, Fountoulakis KN, Courtet P, Naber D, Chan EW, Fagiolini A, Möller HJ, Grunze H, Llorca PM, Jaffe RL, Yatham LN, Hidalgo-Mazzei D, Passamar M, Messer T, Bernardo M, Vieta E.

World J Biol Psychiatry. 2016;17(2):86-128. doi: 10.3109/15622975.2015.1132007. Review.

PMID:
26912127
14.

Diagnostic reliability in schizoaffective disorder.

Murru A, Manchia M, Tusconi M, Carpiniello B, Pacchiarotti I, Colom F, Vieta E.

Bipolar Disord. 2016 Feb;18(1):78-80. doi: 10.1111/bdi.12366. Epub 2016 Feb 15. No abstract available.

PMID:
26877101
15.

Comparison of psychotic bipolar disorder, schizoaffective disorder, and schizophrenia: an international, multisite study.

Tondo L, Vázquez GH, Baethge C, Baronessa C, Bolzani L, Koukopoulos A, Mazzarini L, Murru A, Pacchiarotti I, Pinna M, Salvatore P, Sani G, Selle V, Spalletta G, Girardi P, Tohen M, Vieta E, Baldessarini RJ.

Acta Psychiatr Scand. 2016 Jan;133(1):34-43. doi: 10.1111/acps.12447. Epub 2015 Jun 11.

PMID:
26096273
16.

Management of adverse effects of mood stabilizers.

Murru A, Popovic D, Pacchiarotti I, Hidalgo D, León-Caballero J, Vieta E.

Curr Psychiatry Rep. 2015 Aug;17(8):603. doi: 10.1007/s11920-015-0603-z. Review.

PMID:
26084665
17.

Bipolar disorder and antibodies against the N-methyl-d-aspartate receptor: A gate to the involvement of autoimmunity in the pathophysiology of bipolar illness.

León-Caballero J, Pacchiarotti I, Murru A, Valentí M, Colom F, Benach B, Pérez V, Dalmau J, Vieta E.

Neurosci Biobehav Rev. 2015 Aug;55:403-12. doi: 10.1016/j.neubiorev.2015.05.012. Epub 2015 May 23. Review.

PMID:
26014349
18.

Hyperprolactinemia and medications for bipolar disorder: systematic review of a neglected issue in clinical practice.

Pacchiarotti I, Murru A, Kotzalidis GD, Bonnin CM, Mazzarini L, Colom F, Vieta E.

Eur Neuropsychopharmacol. 2015 Aug;25(8):1045-59. doi: 10.1016/j.euroneuro.2015.04.007. Epub 2015 Apr 14. Review.

PMID:
25937241
19.

Differential effectiveness of right unilateral versus bilateral electroconvulsive therapy in resistant bipolar depression.

Kotzalidis GD, Pacchiarotti I, Rapinesi C, Murru A, Colom F, Vieta E.

Am J Psychiatry. 2015 Mar 1;172(3):294. doi: 10.1176/appi.ajp.2014.14101366. No abstract available.

PMID:
25727540
20.

Risk factors for rapid cycling in bipolar disorder.

Valentí M, Pacchiarotti I, Undurraga J, Bonnín CM, Popovic D, Goikolea JM, Torrent C, Hidalgo-Mazzei D, Colom F, Vieta E.

Bipolar Disord. 2015 Aug;17(5):549-59. doi: 10.1111/bdi.12288. Epub 2015 Feb 12.

PMID:
25682854

Supplemental Content

Loading ...
Support Center